A detailed history of Exodus Point Capital Management, LP transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 15,743 shares of AVIR stock, worth $53,053. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,743
Previous 17,560 10.35%
Holding current value
$53,053
Previous $58,000 8.62%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$3.17 - $4.02 $5,759 - $7,304
-1,817 Reduced 10.35%
15,743 $53,000
Q1 2024

May 14, 2024

SELL
$3.09 - $4.56 $34,898 - $51,500
-11,294 Reduced 39.14%
17,560 $71,000
Q3 2023

Nov 09, 2023

SELL
$3.0 - $3.79 $40,143 - $50,713
-13,381 Reduced 31.68%
28,854 $87,000
Q2 2023

Aug 10, 2023

BUY
$3.21 - $5.06 $135,574 - $213,709
42,235 New
42,235 $158,000
Q3 2022

Nov 10, 2022

SELL
$5.49 - $8.79 $2,382 - $3,814
-434 Reduced 3.7%
11,293 $64,000
Q2 2022

Aug 19, 2022

BUY
$5.33 - $8.18 $62,504 - $95,926
11,727 New
11,727 $83,000
Q1 2022

May 13, 2022

SELL
$5.5 - $9.19 $131,774 - $220,183
-23,959 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$7.67 - $44.59 $183,765 - $1.07 Million
23,959 New
23,959 $214,000

Others Institutions Holding AVIR

About Atea Pharmaceuticals, Inc.


  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $281M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.